Deans' stroke musings: Welcome boost to fatigue research

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 2, 2020

Welcome boost to fatigue research - Australia Stroke foundation

About time.

At least half of all stroke survivors experience fatigue Or is it 70%?

Or is it 40%?

NOTHING THAT WILL CURE IT.

Welcome boost to stroke fatigue research - Australia Stroke foundation

Stroke Foundation has welcomed the announcement of a million dollar boost to help find a treatment for fatigue in stroke survivors.

Funded by the Medical Research Future Fund (MRFF), a specialist team from across Australia and the UK will further explore the use of a common drug used to treat sleep disorders in the long-term recovery of people who experience a stroke. In 2016, Stroke Foundation provided a $50,000 seed funding grant for research on ‘Modafinil in Debilitating fatigue After Stroke (MIDAS)’; the results of which have helped see this trial come to fruition.

Stroke Foundation Research Advisory Committee Chair Professor Amanda Thrift said the trial was a testament to the importance of Stroke Foundation’s pioneering research program.

“Research takes a great deal of time and funding; it is heartening to see this trial take flight,” Professor Thrift said.

“Researchers are now one step closer to finding a treatment for fatigue in people following their stroke. Such a treatment has the potential to benefit and improve the quality of life for so many.

“Stroke Foundation is proud to have contributed to the inception of this significant trial.”

More than 56,000 strokes will be experienced in Australia this year alone and there are more 475,000 survivors of stroke living in the Australian community.

Up to 70 percent of people with stroke will also experience fatigue that is not improved by any amount of rest.

Stroke Foundation Chief Executive Officer Sharon McGowan said the trial would provide hope to the many living with the impact of stroke burdened by fatigue.

“Fatigue is often a less visible effect of stroke, but can be debilitating for so many survivors,” Ms McGowan said.

“This research could transform the lives of so many survivors whose daily activities are impacted by fatigue.

“Stroke Foundation is steadfast in its mission to prevent stroke, save lives and enhance recovery and we are proud to support researchers whose work goes on to make an enormous difference.”